AstraZeneca PLC
AZN
$89.10
$0.490.55%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 9.40B | 8.30B | 7.77B | 7.04B | 6.50B |
| Total Depreciation and Amortization | 5.38B | 5.65B | 5.54B | 5.51B | 5.52B |
| Total Amortization of Deferred Charges | 200.00M | 200.00M | 200.00M | 200.00M | 280.00M |
| Total Other Non-Cash Items | 450.00M | 329.00M | 445.00M | 13.00M | -566.00M |
| Change in Net Operating Assets | -286.00M | -1.08B | -864.00M | -893.00M | -393.00M |
| Cash from Operations | 15.14B | 13.39B | 13.09B | 11.86B | 11.33B |
| Capital Expenditure | -2.48B | -2.21B | -1.94B | -1.92B | -1.74B |
| Sale of Property, Plant, and Equipment | 12.00M | 12.00M | 3.00M | 55.00M | 54.00M |
| Cash Acquisitions | -1.23B | -1.17B | -3.20B | -3.78B | -3.72B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.84B | -2.69B | -1.69B | -2.33B | -2.47B |
| Cash from Investing | -6.54B | -6.06B | -6.82B | -7.98B | -7.88B |
| Total Debt Issued | 819.00M | 756.00M | 1.61B | 6.49B | 7.12B |
| Total Debt Repaid | -412.00M | -2.41B | -5.00B | -5.00B | -5.24B |
| Issuance of Common Stock | 40.00M | 39.00M | 40.00M | 38.00M | 36.00M |
| Repurchase of Common Stock | -508.00M | -570.00M | -567.00M | -81.00M | -81.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -4.97B | -4.94B | -4.94B | -4.63B | -4.63B |
| Other Financing Activities | 99.00M | 126.00M | 128.00M | -817.00M | -817.00M |
| Cash from Financing | -4.93B | -6.99B | -8.73B | -4.00B | -3.62B |
| Foreign Exchange rate Adjustments | -19.00M | 13.00M | -22.00M | -93.00M | -26.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.65B | 355.00M | -2.49B | -208.00M | -184.00M |